News

Published on 10 Aug 2022 on Zacks via Yahoo Finance

Epizyme (EPZM) Q2 Earnings Beat Estimates, Revenues Up Y/Y


Article preview image

Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Novavax, ...

NASDAQ.NVAX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
7 Key Charts to Assess Global Risk Markets This Week | Investing.com India

Market Analysis by Charles-Henry Monchau covering: Silver Spot US Dollar, Silver Futures, BlackRo...

Investing.com 18 Nov 2024

Moderna, Lily, Novavax, and Pfizer stocks fall after Trump nominates RFK Jr. as...

As of the time of this writing, in premarket trading, MRNA shares are sitting around $39.18. Pfiz...

FastCompany · via Yahoo Finance 16 Nov 2024

Why US Futures Are Lower Friday - Alibaba Gr Hldgs (NYSE:BABA), Domino's Pizza...

U.S. stocks could open on a negative note on Friday after the Federal Reserve chair Jerome Powell...

Benzinga 15 Nov 2024

Health stocks slide as Trump picks vaccine skeptic Kennedy

Kennedy Jr. to run the Department of Health and Human Services, potentially elevating a prominent...

Los Angeles Times 15 Nov 2024

Novavax Inc (NVAX) Q3 2024 Earnings Call Highlights: Strategic Partnerships and...

Release Date: November 12, 2024 For the complete transcript of the earnings call, please refer to...

GuruFocus.com · via Yahoo Finance 13 Nov 2024

Earnings call: Novavax outlines strategic growth and partnership with Sanofi By...

Novavax , Inc. (NASDAQ:NVAX), a biotechnology company specializing in vaccine development, report...

Investing.com 12 Nov 2024

Novavax Lowers 2024 Forecast Despite Q3 Revenue Beat, Stock Falls

On Tuesday, Novavax Inc (NASDAQ:NVAX) reported third-quarter 2024 sales of $84.5 million, compare...

Benzinga · via AOL 12 Nov 2024

Novavax Lowers 2024 Forecast Despite Q3 Revenue Beat, Stock Falls

On Tuesday, Novavax Inc (NASDAQ:NVAX) reported third-quarter 2024 sales of $84.5 million, compare...

Benzinga · via Yahoo Finance 12 Nov 2024

FDA Gives Green Signal To Novavax's COVID-19-Influenza Combo Vaccine Late-Stage...

On Monday, the FDA removed the clinical hold on Novavax Inc.’s (NASDAQ:NVAX) Investigational New...

Benzinga · via Yahoo Finance 11 Nov 2024

FDA Gives Green Signal To Novavax's COVID-19-Influenza Combo Vaccine Late-Stage...

On Monday, the FDA removed the clinical hold on Novavax Inc.’s (NASDAQ:NVAX) Investigational New...

Benzinga · via AOL 11 Nov 2024